Literature DB >> 19560115

Risk factors for failure of retropubic and transobturator midurethral slings.

R Marijn Houwert1, Pieter L Venema, Annelies E Aquarius, Hein W Bruinse, Jan Paul W R Roovers, Harry A M Vervest.   

Abstract

OBJECTIVE: The aim of our study was to identify and compare risk factors for failure of retropubic and transobturator procedures. STUDY
DESIGN: This was a retrospective cohort study. Women with predominant stress urinary incontinence who underwent a retropubic (n = 214) or transobturator tape procedure (n = 173) were included. Therapy was considered to have failed in women reporting any amount of urine leakage during stress after 2 and/or 12 months.
RESULTS: Risk factors for failure were mixed urinary incontinence (MUI; odds ratio [OR], 3.7; 95% confidence interval [CI], 1.5-9.1) and the observation of detrusor overactivity (DO) at urodynamics (OR, 8.6; 95% CI, 1.9-39.4) in the retropubic group. Reporting a history of previous incontinence surgery (OR, 3.9; 95% CI, 1.3-11.7) and a low mean urethral closure pressure (MUCP) at urodynamics (OR, 14.5; 95% CI, 1.5-139.0) were risk factors for failure in the transobturator group.
CONCLUSION: Women with previous incontinence surgery or a low MUCP might benefit more from a retropubic sling, whereas a transobturator procedure might be preferable in women with MUI or DO.

Entities:  

Mesh:

Year:  2009        PMID: 19560115     DOI: 10.1016/j.ajog.2009.04.009

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  22 in total

Review 1.  Do urodynamic parameters predict persistent postoperative stress incontinence after midurethral sling? A systematic review.

Authors:  Amie Kawasaki; Jennifer M Wu; Cindy L Amundsen; Alison C Weidner; John P Judd; Ethan M Balk; Nazema Y Siddiqui
Journal:  Int Urogynecol J       Date:  2012-03-09       Impact factor: 2.894

Review 2.  Retropubic versus transobturator midurethral synthetic slings: does one sling fit all?

Authors:  Sarah E McAchran
Journal:  Curr Urol Rep       Date:  2010-09       Impact factor: 3.092

Review 3.  Practical use of the new American Urological Association adult urodynamics guidelines.

Authors:  Bhavin N Patel; Kathleen C Kobashi
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

4.  Should maximal urethral closure pressure be performed before midurethral sling surgery for stress incontinence? A time to revisit.

Authors:  Monika Vij; Anupreet Dua; Robert M Freeman
Journal:  Int Urogynecol J       Date:  2016-03-24       Impact factor: 2.894

5.  A comprehensive look at risk factors for mid-urethral sling revision surgery.

Authors:  Melissa Keslar; Haroutyoun Margossian; Justin E Katz; Nisha Lakhi
Journal:  Int Urogynecol J       Date:  2020-02-07       Impact factor: 2.894

6.  Childbirth after mid-urethral sling surgery: effects on long-term success and complications.

Authors:  Ole A Dyrkorn; Anne C Staff; Sigurd Kulseng-Hanssen; Hjalmar A Schiøtz; Rune Svenningsen
Journal:  Int Urogynecol J       Date:  2019-08-13       Impact factor: 2.894

7.  Demographic and clinical predictors of treatment failure one year after midurethral sling surgery.

Authors:  Holly E Richter; Heather J Litman; Emily S Lukacz; Larry T Sirls; Leslie Rickey; Peggy Norton; Gary E Lemack; Stephen Kraus; Pamela Moalli; Mary Pat Fitzgerald; Kimberly J Dandreo; Liyuan Huang; John W Kusek
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

8.  Incidence and risk factors for reoperation of surgically treated urinary incontinence.

Authors:  Patrick Dällenbach; Carine Luyet; Carol Jungo Nancoz; Michel Boulvain
Journal:  Int Urogynecol J       Date:  2012-10-23       Impact factor: 2.894

Review 9.  Surgical management of female SUI: is there a gold standard?

Authors:  Ashley Cox; Sender Herschorn; Livia Lee
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432

10.  When to perform urodynamics before mid-urethral sling surgery for female stress urinary incontinence?

Authors:  R Marijn Houwert; Jan Paul W R Roovers; Pieter L Venema; Hein W Bruinse; Marcel G W Dijkgraaf; Harry A M Vervest
Journal:  Int Urogynecol J       Date:  2010-03       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.